Bio-Techne Corporation

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Scie…

Biotechnology

US, Minneapolis [HQ]

Financials

Analysts

Wall Street · Earnings · Institutional Sentiment

A comprehensive analysis section that covers unveiling insights about Bio-Techne Corporation's gradings, price targets and earnings estimates.

Earnings

See the historical earnings and what wall street analysts forecasted and
forecast for future earnings.

Reported

Past Estimate Consensus

Future Estimate Consensus

EPS Revenue EBITDA EBIT SGA

All monetary values are presented in USD ($). E stands for Estimate.
FY	EPS		Revenue [mil.]		Profit [mil.]		EBITDA [mil.]		EBIT [mil.]		Expenses · SGA [mil.]
		E		E		E		E		E		E
2014	0.7500	3.380	357	335	110	115	159	178	159	161	60	54
2015	0.7300	0.848	452	451	107	114	147	191	147	152	119	94
2016	0.7000	0.904	499	493	104	99	150	187	150	145	140	127
2017	0.5200	0.904	563	556	77	74	121	166	121	120	199	171
2018	0.8400	1.110	642	636	125	108	136	176	136	119	240	183
2019	0.6400	1.147	714	720	96	91	146	198	146	137	264	237
2020	1.5000	1.075	738	726	229	198	157	342	157	158	260	272
2021	0.9100	1.640	931	924	140	128	237	226	237	139	324	214
2022	1.7300	1.980	1,105	1,104	272	196	397	300	296	238	372	295
2023	1.8100	2.001	1,136	1,142	285	227	406	349	298	278	378	326
2024	-	1.781	-	1,158	-	150	-	384	-	306	-	358
2025	-	1.877	-	1,222	-	310	-	366	-	247	-	424
2026	-	2.183	-	1,335	-	2.F12X/td>	-	2.F121/td>	-	2.F121	-	2.F121
2027	-	2.494	-	1,484	-	1.F13X/td>	-	1.F131/td>	-	1.F131	-	1.F131
2028	-	0.000	-	2,125	-	0.F14X/td>	-	0.F141/td>	-	0.F141	-	0.F141

Institutional Sentiment

Wall Street · Earnings · Institutional Sentiment

The institutional sentiment measures the direction of new stock gradings
and price targets while comparing them Year-over-Year. We've limited the grading institutes to those we see as top-tier and update this data every month.

Morgan Stanley

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

JP Morgan Chase

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

Citigroup

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

Overall Consensus

Here we aggregate the price targets and gradings of all IBs/AMCs/Brokerage firms inside our database to draw a bigger picture.

Grading Consensus

Click to each, to see the grade

Price Target Consensus

-20.197% $14.35 · MISS

Nov. 6, 2024

Price Then

$77.62

Price Target

$85.40

Price Now

$71.05